Manufacture of pharmaceutical preparations
INSULIFE AS
Revenue 2024
NOK 56,000
Operating profit
NOK −13.0m
Equity
NOK 22.1m
Incorporated
2020
Share capital
NOK 72,000
Roles
Daglig lederÅge Nærdal
Regnskapsfører
Revisor
Styrets lederPetter Wessel Bjornstad
StyremedlemPer Heiberg Dybwad
StyremedlemPål Eriksen
StyremedlemAnne Waaler
StyremedlemBjørg Eikeland
StyremedlemGregory David Cash
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| WESSEL CAPITAL LLC | 23.5% | 16831484.000000 | 2025 |
| TRANSDERMAL DELIVERY SOLUTIONS COR | 22.1% | 15875000.000000 | 2025 |
| PHARMAMENTOR AS | 8.5% | 6085050.000000 | 2025 |
| SIRO CLINPHARM PRIVATE LIMITED | 3.5% | 2528850.000000 | 2025 |
| SCANPIPE ENGINEERING AS | 3.3% | 2359000.000000 | 2025 |
| SILVERCOIN INDUSTRIES AS | 2.8% | 2000000.000000 | 2025 |
| SKADI AS | 2.7% | 1966650.000000 | 2025 |
| 3T HOLDING AS | 2.2% | 1580200.000000 | 2025 |
| SMERUD MEDICAL RESEARCH INTERNATIONAL AS | 1.7% | 1219512.000000 | 2025 |
| CHRISTIAN HENRIK THEISTE | 1.4% | 1003666.000000 | 2025 |
| KONSTRUKT HOLDING AS | 1.2% | 865000.000000 | 2025 |
| LETRON AS | 1.0% | 716650.000000 | 2025 |
| CAMACA AS | 1.0% | 716650.000000 | 2025 |
| MOMENT HOLDING AS | 0.8% | 609700.000000 | 2025 |
| TROND DAHL-PEDERSEN | 0.8% | 600350.000000 | 2025 |
| MARIA PATRICIA CONDE | 0.8% | 545000.000000 | 2025 |
| ANDREAS NÆRDAL | 0.7% | 500000.000000 | 2025 |
| VELU HOLDING AS | 0.6% | 435000.000000 | 2025 |
| TANNLEGENE BENTE OG VEGARD BERG AS | 0.6% | 414966.000000 | 2025 |
| MOHAMED ALAMOODI | 0.5% | 368672.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.